Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
View Full LandscapeTarget Indication
Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Clinical Trial
NCT05020015Last updated: 2/9/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Fabry Disease
Type 2 Diabetes Mellitus
Primary Immunodeficiency Diseases (PID)
Primary Immunodeficiency Disease
Hypertension